SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-272415
Filing Date
2023-11-07
Accepted
2023-11-07 16:07:33
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d880282ds3.htm S-3 348953
2 EX-4.3 d880282dex43.htm EX-4.3 343173
3 EX-4.4 d880282dex44.htm EX-4.4 341972
4 EX-4.5 d880282dex45.htm EX-4.5 34173
5 EX-4.6 d880282dex46.htm EX-4.6 34271
6 EX-5.1 d880282dex51.htm EX-5.1 35410
7 EX-23.1 d880282dex231.htm EX-23.1 1731
8 EXHIBIT 107 d880282dexfilingfees.htm EX-FILING FEES 59500
9 GRAPHIC g880282g1102130226088.jpg GRAPHIC 7387
10 GRAPHIC g880282g1102130226283.jpg GRAPHIC 1579
11 GRAPHIC g880282g13e11.jpg GRAPHIC 76298
  Complete submission text file 0001193125-23-272415.txt   1318196
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275364 | Film No.: 231383721
SIC: 2834 Pharmaceutical Preparations